A Chinese scientist reviewing laboratory equipment

Research news

This section contains news items that were not issued as a press release.

Tuesday, 4 December 2012
AstraZeneca to collaborate with the Health and Social Care Information Centre in health data initiative AstraZeneca today announced it has signed a memorandum of understanding with the Health and Social Care Information Centre (HSCIC) to improve the usefulness of real-world data in healthcare decision making and better understand the role medicines play in helping patients with chronic diseases in England.
Thursday, 29 November 2012
AstraZeneca wins Scrip Award for “Best Partnership Alliance” for third consecutive year AstraZeneca’s industry-leading alliance with the UK Medical Research Council (MRC) won the “Best Partnership Alliance” award at the annual Scrip Awards event in London, marking the third consecutive year that AstraZeneca has captured this prestigious award.
Friday, 23 November 2012
Creation of the NĒOMED Institute: renewing biopharmaceutical AstraZeneca Canada and Pfizer Canada join forces with the Government of Québec to establish a new R&D model in the biopharmaceutical industry.
Wednesday, 14 November 2012
AstraZeneca appoints Dr. Shridhar Narayanan to lead infection research in Bangalore BANGALORE, INDIA –AstraZeneca today announced it has appointed Dr. Shridhar Narayanan to the position of Vice President and Head, Infection iScience, Bangalore, effective November 2012.
Monday, 12 November 2012
Foundation Medicine and AstraZeneca announce genomic profiling collaboration Collaboration seeks to enhance clinical trial design by identifying genomic predictors of response to targeted cancer therapies
Friday, 2 November 2012
Experimental Combination Therapy trial for Breast Cancer patients no longer responding to therapy CANCER RESEARCH UK’s Drug Development Office (DDO) has joined forces with academia and industry to trial an experimental drug from AstraZeneca called AZD4547 in combination with existing therapies, to treat post-menopausal women whose breast cancer has spread and is no longer responding to standard treatment.
Wednesday, 31 October 2012
Alzheimer’s, cancer and rare disease research to benefit from landmark MRC-AstraZeneca compound collaboration The Medical Research Council (MRC) will today announce £7 million of funding for 15 research projects awarded through its groundbreaking collaboration with innovative pharmaceutical company AstraZeneca
Monday, 29 October 2012
AstraZeneca and Nobel Media bring Nobel Laureate First AstraZeneca Nobel Medicine Initiative event in Korea aims to inspire local students and scientists.
Tuesday, 16 October 2012
Charles River enters strategic partnership with AstraZeneca Leading Global CRO Partners with Global Biopharmaceutical Company to Accelerate Drug Development
Monday, 15 October 2012
AstraZeneca and Nobel Media present Nobel Laureate on China lecture tour University lectures aim to inspire next generation of Chinese scientists